Heart Lung Machine Market Research, 2033
The global heart lung machine market size was valued at $2.3 billion in 2023, and is projected to reach $4.5 billion by 2033, growing at a CAGR of 6.7% from 2024 to 2033. The heart-lung machine market is driven by the increasing prevalence of cardiovascular diseases, advancements in cardiac surgery techniques, and a growing number of surgical procedures requiring cardiopulmonary bypass. Additionally, technological innovations and improvements in machine safety and efficiency are further propelling heart lung machine market growth.
Market Introduction and Definition
The heart-lung machine, also known as cardiopulmonary bypass (CPB) machine, is a critical medical device used during cardiac surgery to temporarily take over the function of the heart and lungs. It maintains blood circulation and oxygenation in patients undergoing procedures such as open-heart surgery. By diverting blood from the heart, the machine oxygenates it and removes carbon dioxide before returning it to the body, allowing surgeons to operate on a still and bloodless field.
This technology is essential for a range of cardiac interventions, significantly improving surgical outcomes and patient safety. With advancements in design and functionality, modern heart-lung machines are equipped with sophisticated monitoring systems that enhance precision and control during surgery.
Key Takeaways
- The heart lung machine industry study covers 20 countries. The research includes a segment analysis of each country in terms of value ($Billion) for the projected period 2023-2033.
- More than 1, 500 product literatures, industry releases, annual reports, and other such documents of major heart lung machine industry participants along with authentic industry journals, trade associations' releases, and government websites have been reviewed for generating high-value industry insights.
- The study integrated high-quality data, professional opinions and analysis, and critical independent perspectives. The research approach is intended to provide a balanced view of global markets and to assist stakeholders in making educated decisions in order to achieve their most ambitious growth objectives.
Key Market Dynamics
The heart lung machine market size is primarily driven by the increasing prevalence of cardiovascular diseases, which necessitate complex surgical interventions like open-heart surgeries. According to the World Health Organization, cardiovascular diseases account for approximately 31% of all global deaths, highlighting the critical need for advanced medical equipment. Additionally, advancements in technology, such as the development of more compact and efficient heart-lung machines, enhance surgical outcomes and patient safety, are further propelling heart lung machine market growth.
However, the market faces certain restraints, including the high costs associated with heart-lung machines and the stringent regulatory approvals required for medical devices. The initial investment and maintenance costs can be prohibitive for smaller healthcare facilities, limiting access to this vital equipment. Furthermore, the complexity of operating these machines requires skilled personnel, which can be a barrier in regions with a shortage of trained healthcare professionals.
Despite these challenges, significant opportunities lie in emerging markets, where rising healthcare expenditure and increasing awareness of cardiovascular health are driving demand for advanced surgical solutions. For instance, the Asia-Pacific region is expected to witness substantial growth in the heart-lung machine market, fueled by a growing aging population and rising incidences of heart-related ailments.
Moreover, the introduction of innovative solutions, such as portable heart-lung machines, presents an opportunity to improve accessibility and convenience in critical care settings, thus expanding the market further during heart lung machine market forecast.
Market Segmentation
The heart lung machine market is segmented into component, application, end user and region. On the basis of component, the market is classified into oxygenator, pump, cannula, monitoring system, heat exchange unit, blood reservoir and others. Based on application, the market is segmented into coronary artery bypass grafting (CABG) , heart valve surgeries, heart transplant, lung transplant, and others. Based on end user, the market is divided into hospitals, cardiac centers, and others. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Regional/Country Market Outlook
North America has largest heart lung machine market share and is driven by several key factors. Firstly, the increasing prevalence of cardiovascular diseases and related surgical procedures necessitates advanced cardiopulmonary support systems, which heart-lung machines provide. The aging population also contributes significantly to market growth, as older adults are more prone to heart conditions requiring surgical interventions. Additionally, technological advancements in heart-lung machines, including improved safety features and enhanced functionalities, attract healthcare facilities looking to optimize patient outcomes.
The growing number of cardiac surgeries, along with rising investments in healthcare infrastructure, further fuels demand for these devices. Moreover, the focus on research and development to innovate and improve heart-lung machine performance is expected to drive the market forward. Finally, supportive government initiatives and funding for cardiovascular research enhance the overall growth potential in this segment.
Industry Trends
- Innovations in heart-lung machines, such as miniaturization, improved biocompatibility, and enhanced monitoring capabilities, are driving market growth. Integration with advanced imaging and data analytics improves surgical outcomes.
- The increasing prevalence of cardiovascular diseases and a growing number of surgeries, including coronary artery bypass grafting (CABG) and heart transplants, are boosting demand for heart-lung machines.
Patent Analysis, By Country, 2015-2024
U.S. witnessed the highest number of patent approvals and applications, due to favorable government policies, new technological advancement and new product launches in the country. China has 22.6% of the total number of patents, followed by PCT at 14.29%.
Competitive Landscape
The major heart lung machine market share players operating in the market include Medtronic plc., Terumo Corporation, Getinge AB, Sorin Group, LivaNova PLC, Fresenius SE & Co. KGaA, Boston Scientific Corporation, Cardinal Health, Inc., Nipro Corporation, Asahi Kasei Corporation. Other players in heart lung machine market include Corys FSP, Xenios AG, Kohler Medizintechnik GmbH, MedeAnalytics, Inc., B. Braun Melsungen AG and so on.
Recent Key Strategies and Developments
- In March 2023, LivaNova PLC received U.S. Food and Drug Administration (FDA) 510 (k) clearance for its Essenz Heart-Lung Machine (HLM) . With FDA clearance, LivaNova initiates the commercial launch of Essenz in the U.S. The company also recently received approval for the Essenz HLM from Health Canada and the Japanese Pharmaceuticals and Medical Devices Agency (PMDA) . Additionally, LivaNova is initiating a broad commercial release in Europe, following a successful limited commercial release that supported more than 200 adult, pediatric and neonatal patients in Europe.
Key Benefits For Stakeholders
- This report provides a quantitative analysis of the heart lung machine market segments, current trends, estimations, and dynamics of the heart lung machine market analysis from 2023 to 2033 to identify the prevailing heart lung machine market opportunity.
- The market research is offered along with information related to key drivers, restraints, and opportunities.
- Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the heart lung machine market segmentation assists to determine the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global heart lung machine market statistics.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes the analysis of the regional as well as global heart lung machine market trends, key players, market segments, application areas, and market growth strategies.
Key Sources Referred
- Centers for Disease Control and Prevention
- World Health Organization
- National Center for Biotechnology Information
- The Lancet
- National Perinatal Epidemiology and Statistics Unit (NPESU)
- Science Direct
- Health Resources and Services Administration (HRSA)
- Department of Health and Human Services (HHS)
- National Institutes of Health (NIH)
- GOV.UK
Heart Lung Machine Market , by Component Report Highlights
| Aspects | Details |
 Market Size By 2033 | USD 4.5 Billion |
 Growth Rate | CAGR of 6.7% |
 Forecast period | 2024 - 2033 |
 Report Pages | 260 |
 By Component |
|
 By Application |
|
 By End User |
|
 By Region |
|
 Key Market Players | Boston Scientific Corporation, Getinge AB, Cardinal Health, Inc., Sorin Group., Medtronic plc, Asahi Kasei Corporation, Nipro Corporation, Terumo Corporation, LivaNova PLC, Fresenius SE & Co. KGaA |
The Medtronic plc., Terumo Corporation, Getinge AB, Sorin Group, LivaNova PLC, Fresenius SE & Co. KGaA, Boston Scientific Corporation held a high market position in 2023.
The base year is 2023 in heart lung machine market.
The forecast period for heart lung machine market is 2024 to 2033.
The market value of heart lung machine market is projected to reach $4.5 billion by 2033.
The total market value of heart lung machine market was $2.3 billion in 2023.
Loading Table Of Content...
